Skip to main content

Table 2 Prevalence of comorbidities among the study cohort (n = 1853)

From: Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia

Comorbidity

Number (%)

Hypertension

232 (12.5%)

Cardiovascular disease

116 (6.3%)

Chronic respiratory disease

116 (6.3%)

Chronic renal disease

199 (10.3%)

Chronic liver disease

32 (1.7%)

Dementia

45 (2.4%)

Chronic neurological disease

146 (7.9%)

Connective tissue disease

30 (1.6%)

Diabetes mellitus

899 (48.5%)

HIV/AIDS

1 (0.1%)

Malignancy

39 (2.1%)